Annual Meeting Recorded Events

As part of its commitment to providing 24/7 access to high-quality educational materials, ACCP records Workshops and Symposia from its Annual Meeting and makes those courses available On Demand for up to three years.

Available courses are listed below. Click on the course title for more details on the course and registration information. The Member price for each course is $25; the Non-member price is $75. 

2016 ACCP Annual Meeting 

Clinical Pharmacology as a Cornerstone for Development of Products Under the Animal Rule: Determining an Effective Dose in Humans
 
3.5 hours / Offers both CME and CPE Credit

A 360 View of Immunogenicity: Qualitative & Quantitative Assessments to Understand Its Implications on Pharmacokinetics, Safety & Efficacy

Helping Advance the Immuno-Oncology Revolution: Trends in Translational Immuno-Oncology

Addressing Opioid Dependence: Now is the Time

Treatment of Hepatitis C with Direct-acting Antiviral Drugs: Opportunities & Challenges (offers CE)
2 hours / Offers both CME and CPE Credit / Supported in part by an Educational Grant from Merck Sharpe & Dohme Corp (A subsidiary of Merck & Co Inc)  


2015 ACCP Annual Meeting 

Oncology Immunotherapy: The Next Era of Treating Cancer

Considerations for the Clinical Pharmacology of Nucleic Acid Therapeutics

Novel Approaches to First-in-Human Studies

Current and Emerging Therapies for the Treatment for Cancer Cachexia
3 hours / Offers both CME and CPE Credit


2014 ACCP Annual Meeting

Opioid Prescribing:  Reducing the Risks
3 hours / Offers both CME and CPE Credit / Supported by an Educational Grant from Purdue Pharma LP

Systems Approaches in Drug Development
3 hours / Offers CPE Credit / Supported by an Educational Grant from AbbVie Inc

Opportunities in Antimicrobial Development
3.5 hours / Offers both CME and CPE Credit / Supported by an Educational Grant from Cubist Pharmaceuticals Inc

Opportunities and Challenges in New Antibiotic Development
2 hours / Offers both CME and CPE Credit / Supported by an Educational Grant from Cubist Pharmaceuticals Inc

Pragmatic Assessment of Pro-arrhythmic Risk During Drug Development
3.5 hours / Offers both CME and CPE Credit / Supported by Educational Grants from Bristol-Myers Squibb and Pfizer Inc

Cardiovascular Diseases:  Drug Discovery to Recovery
3.5 hours / Offers both CME and CPE Credit / Supported by Educational Grants from Bristol-Myers Squibb and Pfizer Inc